Quick answer: Prediabetes — defined as fasting glucose 100–125 mg/dL or HbA1c 5.7–6.4% — affects 96 million Americans (38% of the adult population), with 70% progressing to type 2 diabetes within 10 years if untreated, yet the CDC’s National Diabetes Prevention Program demonstrates that intensive lifestyle intervention (7% weight loss + 150 minutes/week moderate exercise) reduces diabetes progression by 58% — superior to metformin’s 31% reduction — establishing lifestyle medicine as the primary intervention for prediabetes reversal.
Prediabetes is not a pre-disease — it is a disease. At HbA1c levels considered “prediabetic” (5.7–6.4%), cardiovascular disease risk is already elevated, kidney function begins declining, retinal changes occur, and cognitive impairment accelerates. The conventional approach — “watch and wait, consider metformin if progression occurs” — is a missed opportunity: prediabetes is the ideal intervention window, where the metabolic damage is largely reversible and the trajectory toward full type 2 diabetes and its irreversible complications is most amenable to change. Functional medicine’s comprehensive approach to prediabetes — addressing insulin resistance through its multiple upstream drivers — achieves reversal (normalization of glucose and insulin metrics) in a substantial proportion of motivated patients.
Understanding Insulin Resistance: The Spectrum and Its Consequences
Insulin resistance — the inability of insulin to drive glucose uptake efficiently at normal plasma insulin concentrations — is the central defect in prediabetes and type 2 diabetes, preceding frank glucose elevation by 10–15 years (DeFronzo 1988). During this decade-plus prodromal period, the pancreatic beta cells compensate by secreting increasing insulin quantities to maintain normal glucose — the hyperinsulinemic euglycemic phase. Insulin resistance is therefore best detected not by glucose testing (which remains normal until beta cell compensation fails) but by insulin measurement: fasting insulin above 5–8 μIU/mL suggests early insulin resistance; above 10 μIU/mL is significant; above 15 suggests metabolic syndrome; HOMA-IR (fasting insulin × fasting glucose / 405) above 2.0 indicates IR. Joseph Kraft’s 5-hour glucose and insulin OGTT is the most sensitive test — identifying “diabesity” in patients with completely normal fasting glucose and HbA1c through post-prandial insulin patterns.
The consequences of chronic hyperinsulinemia extend far beyond glucose: insulin is a growth factor that promotes adipose tissue expansion (particularly visceral), drives hepatic lipogenesis and NAFLD, promotes atherosclerosis through IGF-1R on arterial smooth muscle cells (insulin hypothesis of atherosclerosis — Stout 1990), drives polycystic ovarian syndrome (PCOS) through ovarian theca cell stimulation, fuels cancer cell proliferation through PI3K/mTOR activation, and accelerates cognitive decline through brain insulin resistance (type 3 diabetes — Steen 2005). Treating insulin resistance is not simply diabetes prevention — it is simultaneous prevention of cardiovascular disease, NAFLD, PCOS, cancer, and neurodegeneration.
The Multiple Drivers of Insulin Resistance
Insulin resistance has multiple simultaneous drivers — a truth that explains why single-intervention approaches (diet alone, exercise alone, metformin alone) are often insufficient and why functional medicine’s multi-pronged approach produces superior outcomes. The major drivers: (1) Excess dietary refined carbohydrate and sugar — driving postprandial glucose spikes → insulin surges → receptor downregulation → IR; (2) Visceral adiposity — visceral fat releases free fatty acids (FFAs) into portal circulation → hepatic insulin resistance; releases adipokines (TNF-α, IL-6, resistin, low adiponectin) that impair insulin signaling; (3) Mitochondrial dysfunction — Kelley 2002 documented “metabolic inflexibility” in insulin resistance: impaired ability to switch between fat and glucose oxidation; intramyocellular lipid accumulation (IMCL) from dysfunctional mitochondria impairs IRS-1 phosphorylation and insulin signaling; (4) Gut dysbiosis and metabolic endotoxemia — Cani 2007 demonstrated that LPS from dysbiotic gut microbiome drives TNF-α → serine phosphorylation of IRS-1 → insulin receptor desensitization; (5) Chronic psychological stress — cortisol directly induces hepatic insulin resistance and promotes gluconeogenesis; (6) Sleep disruption — even one week of sleep restriction (5 hours/night) reduces insulin sensitivity 25% (Nedeltcheva 2009, Annals of Internal Medicine); (7) Environmental toxins — BPA, phthalates, PFAS, and organophosphates disrupt insulin signaling pathways and promote IR.
Dietary Strategies for Insulin Resistance Reversal
The optimal dietary approach for insulin resistance reversal is still debated, but several patterns have the strongest evidence: Very low-carbohydrate/ketogenic — the most rapidly effective intervention for reducing fasting insulin and glucose; Westman 2008 (Nutrition & Metabolism) RCT found VLCKD reduced HbA1c from 8.8% to 7.3% in type 2 diabetes versus low-GI diet reduction of 8.5% to 8.1%. Virta Health’s 2-year controlled study (McKenzie 2021, Frontiers in Endocrinology) found ketogenic diet produced 53.5% complete diabetes reversal (HbA1c <6.5% off medications) vs 5.9% control — the most clinically significant diabetes reversal evidence in the literature. Mediterranean diet — Esposito 2004 (JAMA, n=180) found Mediterranean diet reduced insulin resistance (HOMA-IR) 48% versus low-fat control at 2 years, with 44% of patients achieving metabolic syndrome resolution. PREDIMED trial (Estruch 2013, NEJM, n=7,447) demonstrated 30% cardiovascular event reduction — the most powered dietary RCT in history. Time-restricted eating (TRE) — eating within a consistent 6–10 hour window (e.g., 12pm–8pm) aligns food intake with circadian insulin sensitivity (which peaks in the morning, declines through the day), reduces postprandial glucose, improves insulin sensitivity, and achieves caloric restriction effects without calorie counting. Sutton 2018 (Cell Metabolism) RCT (n=8, metabolic syndrome men) found 5-week 6-hour TRE (eating window 8am–2pm) dramatically improved insulin sensitivity, blood pressure, and oxidative stress without weight loss — establishing the independent metabolic benefits of meal timing.
Exercise Prescription for Insulin Resistance Reversal
Exercise is the most potent tool for improving insulin sensitivity through mechanisms that are entirely independent of diet: GLUT4 transporter translocation to the skeletal muscle cell membrane (both during and for 24–48 hours after exercise) allows insulin-independent glucose uptake; AMPK activation (the “energy sensor”) inhibits mTOR and promotes fat oxidation and mitochondrial biogenesis. The DPP (Diabetes Prevention Program) found 150 minutes/week of moderate exercise (brisk walking) reduced diabetes progression by 58% — more effective than metformin (31% reduction). For optimal insulin sensitivity, the evidence supports combining: Resistance training — skeletal muscle is the primary site of insulin-stimulated glucose disposal (80% of post-meal glucose uptake); adding 4.5 kg of muscle increases glucose disposal capacity by ~45%; Church 2010 (JAMA) found combined aerobic + resistance training produced greater HbA1c reduction than either alone in type 2 diabetes; HIIT — 2–4 sessions weekly of 4×4 minute intervals at 90–95% VO2 max reduces fasting insulin significantly more than moderate continuous exercise (Tjønna 2008, Circulation); Post-meal walks — 10-minute walk after each meal reduces postprandial glucose 12% compared to 30-minute single walk (Colberg 2009) — the most practical glucose-flattening behavior available.
Pharmacological and Nutraceutical Interventions
Metformin — first-line pharmacological choice; reduces hepatic gluconeogenesis (AMPK activation), reduces intestinal glucose absorption, improves gut microbiome (enriches Akkermansia), and may extend healthspan through mTOR-independent mechanisms (TAME trial). Evidence: DPP 31% diabetes prevention vs lifestyle’s 58% — metformin is second-line to lifestyle but appropriate adjunct for high-risk patients. Berberine — an alkaloid from Berberis species with meta-analysis evidence equivalent to metformin for HbA1c reduction; Zhang 2008 (Journal of Clinical Endocrinology & Metabolism) RCT found berberine 0.5g three times daily reduced HbA1c from 9.5% to 7.5% versus metformin reduction from 9.5% to 8.1% — statistically equivalent. Mechanism: AMPK activation, SGLT inhibition, gut microbiome modulation. Dose: 500mg two to three times daily with meals. Chromium — essential cofactor for insulin receptor signaling via chromodulin; deficiency impairs insulin response; Anderson 1997 (Diabetes) RCT (n=180 Chinese type 2 diabetics) found chromium picolinate 1,000μg daily reduced HbA1c from 8.5% to 7.5% and fasting insulin significantly. Magnesium — cofactor for all insulin receptor tyrosine kinase activity; hypomagnesemia is twice as prevalent in diabetics; Rodríguez-Morán 2003 (Diabetes Care) RCT confirmed oral magnesium supplementation improved insulin sensitivity significantly. ALA (alpha-lipoic acid) — improves GLUT4 translocation independently of insulin through PI3K; reduces oxidative stress impairing insulin signaling; Jacob 1999 (Free Radical Biology and Medicine) RCT found ALA significantly improved whole-body glucose disposal in type 2 diabetes.
Continuous Glucose Monitoring: The Prediabetes Game-Changer
Continuous glucose monitoring (CGM) — devices like the FreeStyle Libre, Dexterity G7, and Dexterity G7+ — provide real-time glucose readings every 5 minutes for 10–14 days, revealing the postprandial glucose patterns that single fasting measurements entirely miss. For prediabetes management, CGM is transformative: it shows which foods spike glucose in a specific individual, reveals the impact of sleep deprivation and stress on glucose control, demonstrates the glycemic benefit of exercise timing (post-meal walks), and provides motivating real-time biofeedback that drives behavioral change. Zeevi et al. (2015, Cell, n=800) used CGM in 800 healthy and prediabetic individuals and found that the same foods produced dramatically different glycemic responses between individuals — demonstrating that personalized dietary recommendations based on individual CGM data outperform standard one-size-fits-all dietary guidelines. CGM is now accessible to non-diabetics without a prescription through companies like NutriSense and Levels — a genuine democratization of metabolic monitoring.
Frequently Asked Questions: Prediabetes and Insulin Resistance
Can prediabetes be reversed?
Yes — prediabetes is highly reversible, particularly with early, intensive intervention. The CDC’s National Diabetes Prevention Program showed 58% reduction in progression to diabetes with lifestyle intervention (7% body weight loss + 150 minutes/week moderate exercise). Virta Health’s 2-year study of ketogenic diet showed 53.5% complete diabetes reversal in type 2 diabetics (achieving HbA1c <6.5% off all diabetes medications) — with even better results expected in the less-progressed prediabetes population. Remission is defined as achieving normal glucose and insulin metrics (fasting glucose <100 mg/dL, HbA1c <5.7%, fasting insulin <5-8 μIU/mL, HOMA-IR <2.0) without medication. This is achievable in motivated patients with comprehensive lifestyle and nutritional intervention.
What is the best diet for prediabetes?
The most effective dietary patterns for prediabetes reversal are: very low-carbohydrate/ketogenic diet (most rapidly reduces fasting insulin and glucose; Virta Health 2-year study: 53.5% complete diabetes reversal); Mediterranean diet (48% HOMA-IR reduction in 2-year RCT; 30% cardiovascular event reduction in PREDIMED n=7,447); and time-restricted eating (6-10 hour eating window aligned with circadian insulin sensitivity peaks). All three approaches reduce postprandial glucose spikes, lower fasting insulin, and improve insulin sensitivity through partially overlapping mechanisms. The optimal diet is the one a patient can sustainably maintain — personalized CGM monitoring to identify individual glycemic responses is more valuable than any generic dietary prescription.
Is metformin necessary for prediabetes?
Metformin reduces prediabetes-to-diabetes progression by 31% — less effective than lifestyle intervention’s 58% reduction in the DPP study. It is not necessary for all prediabetes patients, but is appropriate as an adjunct in high-risk individuals (BMI >35, age <60, prior gestational diabetes, HbA1c >6.0%) who cannot achieve sufficient lifestyle change, or as a complement to lifestyle intervention. Natural alternatives with equivalent HbA1c-lowering evidence include berberine 500mg three times daily (meta-analysis shows comparable efficacy to metformin for HbA1c reduction with additional microbiome benefits). Regardless of metformin decision, lifestyle intervention — particularly 150+ minutes/week moderate exercise and dietary modification — should be the primary approach.
What tests detect insulin resistance before blood sugar rises?
Insulin resistance begins 10-15 years before fasting glucose becomes abnormal. Early detection requires: fasting insulin (target <5-8 μIU/mL; levels above 10 indicate meaningful resistance), HOMA-IR (fasting insulin × fasting glucose ÷ 405; target <2.0), triglyceride/HDL ratio (>2.0 in a non-fasted state is a validated insulin resistance surrogate), Kraft 5-hour glucose and insulin OGTT (most sensitive — identifies insulin resistance patterns in patients with completely normal fasting glucose and HbA1c), and continuous glucose monitoring for 10-14 days (reveals postprandial patterns and time-in-range metrics). These tests identify and quantify insulin resistance years before conventional diabetes screening would flag any abnormality.
Prediabetes reversal is one of the most impactful and achievable interventions in all of medicine — yet most patients receive nothing more than advice to “eat better and exercise” without the specific testing, personalized protocols, and accountability structures that make reversal actually happen. The Private Practice specializes in comprehensive metabolic evaluation and evidence-based prediabetes reversal programs including CGM monitoring, advanced insulin resistance testing, and personalized dietary and supplementation protocols. Call (810) 206-1402 to schedule your metabolic evaluation.